Global Transfection Reagents and Equipment Market 2022-2028
Gen Consulting Company predicts global transfection reagents and equipment market will grow from USD 1,003 million in 2021 to USD 1,752 million by 2028, achieving a CAGR of 8.5 percent, according to the latest edition of the Global Transfection Reagents and Equipment Market Report.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global transfection reagents and equipment market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the transfection reagents and equipment industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, method, application, and region. The global market for transfection reagents and equipment can be segmented by product: reagent, equipment. In 2021, the reagent segment made up the largest share of revenue generated by the transfection reagents and equipment market. Transfection reagents and equipment market is further segmented by method: electroporation, liposomes, particle bombardment, microinjection, adenoviral vectors, microinjection, calcium phosphate, diethylaminoethyl (DEAE)-dextran, magnetic beads, activated dendrimers, laserfection. The electroporation segment was the largest contributor to the global transfection reagents and equipment market in 2021. Based on application, the transfection reagents and equipment market is segmented into: gene expression study, protein production, transgenic models, therapeutic delivery, cancer research, biomedical research, others. The gene expression study segment is estimated to account for the largest share of the global transfection reagents and equipment market. On the basis of region, the transfection reagents and equipment market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global transfection reagents and equipment market in 2021 and is anticipated to hold its share during the forecast period.
Market Segmentation
By product: reagent, equipment
By method: electroporation, liposomes, particle bombardment, microinjection, adenoviral vectors, microinjection, calcium phosphate, diethylaminoethyl (DEAE)-dextran, magnetic beads, activated dendrimers, laserfection
By application: gene expression study, protein production, transgenic models, therapeutic delivery, cancer research, biomedical research, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides analysis of the key companies of the industry and their detailed company profiles including Bio-Rad Laboratories Inc., Lonza Group AG, MaxCyte, Inc., Merck KGaA, OriGene Technologies, Inc., PerkinElmer, Inc., Promega Corporation, Qiagen N.V., Roche Holding AG, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook